New evidence explains poor infant immune response to certain vaccines

April 1, 2009

For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop. Now, in a new study from the University of Missouri, one researcher has found an explanation for that poor response. In the study, the MU scientist found evidence that the immune systems of newborns might require some time after birth to mature to a point where the benefits of vaccines can be fully realized.

Habib Zaghouani, a professor of molecular microbiology and immunology and at the MU School of Medicine, recently found that a slowly maturing component of the might explain why newborns contract infections easily. In his work, Zaghouani studied newborn mice and how their immune systems reacted when they were repeatedly exposed to an antigen that simulates a virus.

Zaghouani found that while the antigen would prompt a response of the immune system, it was not the expected response. In the adult immune system, two major types of cells, known as T-helper 1 (Th-1) and T-helper 2 (Th-2) cells, are instrumental in the development of an effective . Typically, Th-1 cells respond when dangerous microbes enter the body. The Th-1 cells then work to help destroy the foreign microbes. When an antigen from a enters a body with a mature immune system, Th-1 cells respond and, after destroying the invader, the Th-1 cells "remember" how to fight the antigen for future battles. Th-2 cells typically develop when the body is exposed to allergens. The responses of Th-2 cells are usually strong and manifest in the form of .

When Zaghouani gave the newborn mice an antigen shortly after birth, he noticed the presence of both Th-1 and Th-2 cells. However, when he gave the antigen a second time, he noticed an abundance of Th-2 cells that responded to the antigen instead of Th-1 cells. Zaghouani was surprised to notice that the Th-2 cells worked to destroy the small contingent of Th-1 cells that had responded to the antigen given at birth.

"Perhaps we should test vaccines at a very early age in animals to establish a regimen with the most effectiveness," Zaghouani said.

When a baby first gets an infection, the immature immune system responds with both types of T cells. Unfortunately, Th-1 cells have an unusual receptor that binds to a specific hormone, which is deadly to the Th-1 cells. Ironically, this particular hormone is produced by the Th-2 cells. This results in an overabundance of Th-2 cells during the first few days of life.

"We found that after six days, the immune systems in the mice matured enough to stop the death of the Th-1 cells," Zaghouani said. "After those initial days, the immune system is producing Th-1 cells with diminished hormonal receptors, thus surviving the effect of the compound that the Th-2 cells make."

More information: Zaghouani's publication, "Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity," was published in The Journal of Experimental Medicine.

Source: University of Missouri-Columbia (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet

Rank Filter

Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

  • Ashy - Apr 02, 2009
    • Rank: not rated yet
    For years many parents told doctors to not shot their children. Doctors shot and many children become feeble, invalid, and dead.

April 1, 2009 all stories

Comments: 1

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Researchers discover novel way to develop tumor vaccines
    created Mar 02, 2008 | popularity not rated yet | comments 0
  • Study: Tumors inhibit immune system
    created May 29, 2006 | popularity not rated yet | comments 0
  • Gene therapy protocol activates immune system in patients with leukemia
    created Feb 11, 2008 | popularity not rated yet | comments 0
  • 'Killer' B cells provide new link in the evolution of immunity
    created Oct 03, 2006 | popularity not rated yet | comments 0
  • Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine
    created Apr 15, 2007 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

  • Improving the brain through chemistry
    created Nov 07, 2009
  • Sleep / REM Sleep and homeostasis
    created Nov 07, 2009
  • The Biceps Reflex
    created Nov 05, 2009
  • Consequenses of striking a Vein and an artery?
    created Nov 05, 2009
  • More from Physics Forums - Medical Sciences

Other News

New York residents walk on the sidewalk  in Manahattan in New York

Path to good health, less pollution is the sidewalk: report

Medicine & Health / Health

created 45 minutes ago | popularity not rated yet | comments 0

US pressure groups joined forces Monday to urge authorities to spend more to improve Americans' health and cut greenhouse gas emissions.


Connection between depression and osteoporosis detailed

Medicine & Health / Psychology & Psychiatry

created 3 minutes ago | popularity not rated yet | comments 0

Research carried out among thousands of people has shown a clear connection between depression and a loss of bone mass, leading to osteoporosis and fractures.


For young boys with cancer, testicular tissue banking may be option to preserve fertility

Medicine & Health / Cancer

created 34 minutes ago | popularity not rated yet | comments 0

For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news—treatments that enable survival often cause infertility.


AIDS is leading cause of death, disease for women

Medicine & Health / HIV & AIDS

created 55 minutes ago | popularity 5 / 5 (1) | comments 0

(AP) -- In its first study of women's health around the globe, the World Health Organization said Monday that the AIDS virus is the leading cause of death and disease among women between the ages of 15 and 44.


St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial

Medicine & Health / Cancer

created 1hour ago | popularity not rated yet | comments 0

St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first ...